Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced
FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal
Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and
Bevacizumab Concurrent with Chemotherapy and in Maintenance.
Phase:
Phase 3
Details
Lead Sponsor:
Arcagy Research ARCAGY/ GINECO GROUP
Collaborators:
Arbeitsgemeinschaft Gynaekologische Onkologie Austria Arbeitsgemeinschaft Gynaekologishe Onkologie Germany Belgian Gynaecological Oncology Group Grupo Español de Investigación en Cáncer de Ovario Gynecologic Oncology Trial & Investigation Consortium Mario Negri Gynecologic Oncology Mario Negri Gynecologic Oncology group (MaNGO) Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies Nordic Society for Gynaecologic Oncology Nordic Society of Gynaecological Oncology - Clinical Trials Unit